Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04407364 · ClinicalTrials.gov registry record
MPM Medical CoMatryx Surgical Bovine Collagen Study
A clinical trial of Surgical Wound, Healed, sponsored by MPM Medical.
- Active
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT04407364 is a study of Surgical Wound, Healed that is active but no longer recruiting, run by MPM Medical. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04407364, a study of Surgical Wound, Healed, is active but no longer recruiting, sponsored by MPM Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery. The primary objective is to confirm safety and clinical benefits of the product. This will be assessed by recording the rate of wound healing and incidence and frequency of wound care related complications. Relationship of complications to the product should be specified.
Conditions Studied
Interventions
- DEVICE CoMatryx Surgical Bovine Collagen
Study Locations (1)
Texas
- Texas Center for Joint Replacement - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2020-09-02 |
| Est. Completion | 2025-05-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04407364
The ClinicalTrials.gov registry entry for NCT04407364 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MPM Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Surgical Wound, Healed appearing as the primary indexed condition, and to 1 intervention - of which CoMatryx Surgical Bovine Collagen is the first listed.
NCT04407364 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04407364 about?
NCT04407364 is a clinical study titled "MPM Medical CoMatryx Surgical Bovine Collagen Study". The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery. The ...
What is the current status of trial NCT04407364?
This trial is currently active not recruiting. The enrollment target is 72 participants. The study started on 2020-09-02. Estimated completion is 2025-05-02.
What conditions does trial NCT04407364 study?
This clinical trial studies the following conditions: Surgical Wound, Healed.
What interventions are being tested in trial NCT04407364?
The interventions under investigation include: CoMatryx Surgical Bovine Collagen (DEVICE).
Who is sponsoring clinical trial NCT04407364?
This trial is sponsored by MPM Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04407364 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.